Study of Heart and Renal Protection (SHARP)
- 1 May 2003
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 63 (84), S207-S210
- https://doi.org/10.1046/j.1523-1755.63.s84.4.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Pravastatin Therapy and the Risk of StrokeNew England Journal of Medicine, 2000
- Premature cardiovascular disease in chronic renal failureThe Lancet, 2000
- Non-lipid-related effects of statinsAnnals of Medicine, 2000
- Clinical epidemiology of cardiovascular disease in chronic renal diseaseAmerican Journal of Kidney Diseases, 1998
- Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality studyEuropean Heart Journal, 1994
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993
- Lipids and the kidney.Hypertension, 1990
- Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between FacilitiesAmerican Journal of Kidney Diseases, 1990